查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1922978

醫用血袋市場：按血液成分、產品類型、材料、技術、應用、最終用戶和通路分類 - 全球預測（2026-2032年）

Medical Blood Bag Market by Blood Component, Product Type, Material, Technology, Application, End User, Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用血袋市場價值將達到 22.6 億美元，到 2026 年將成長至 23.9 億美元，到 2032 年將達到 32.8 億美元，年複合成長率為 5.45%。

關鍵市場統計數據
基準年 2025 22.6億美元
預計年份：2026年 23.9億美元
預測年份 2032 32.8億美元
複合年成長率 (%) 5.45%

簡要概述影響醫用血袋開發和臨床應用的關鍵技術、監管和營運變數。

以下執行摘要概述了影響醫用血袋行業的當代趨勢，並為包括製造商、採購商、臨床輸血服務機構和研究機構在內的所有相關人員提出了關鍵考慮因素。它簡要概述了正在重新定義產品需求、材料選擇和通路的技術、監管和營運變數。本導言將幫助您了解過濾技術、材料科學和供應鏈管理的進步如何與不斷發展的臨床最佳實踐相融合，從而推動產品設計和部署的重大變革。

新興材料技術、過濾技術的進步以及供應鏈的數位化正在融合，重新定義血袋產業的競爭優勢。

血袋產業正經歷著變革性的轉變，這主要得益於技術改進、材料創新以及臨床需求的不斷提高。整合式白血球去除過濾器技術的進步以及與添加劑溶液相容性的提升，迫使製造商重新評估血袋的結構和組裝過程。同時，人們越來越傾向於選擇EVA和PE等非PVC材料，這促使各機構權衡PVC的既有性能與其長期生物相容性和環境影響，從而重新評估資本投資並尋求供應商多元化。

政策主導的關稅趨勢正在鼓勵製造商建立區域韌性、雙重採購和營運效率，以保護利潤和供應。

影響醫療設備原料的關稅調整和貿易政策變化，為在美國運營的製造商和採購專業人員帶來了戰略上的複雜性。為此，各公司正在進行有針對性的採購審查，以確定關稅對聚合物樹脂、特殊過濾器和組裝組件等原料到岸成本和供應商選擇標準的影響。這種日益嚴格的關稅審查促使許多企業重新評估其區域製造地，探索近岸生產方案，並加強供應商關係管理，以降低跨境成本波動的風險。

以細分市場為中心的分析揭示了組件、產品類型、材料、最終用戶、通路、應用和技術等變數如何驅動差異化產品和商業化策略。

詳細的細分市場分析揭示了不同維度（例如組件、產品類型、材料、最終用戶、通路、應用和技術）的需求促進因素和產品要求的差異。基於血液成分，產品開發和庫存規劃必須滿足冷沉澱、血漿、血小板和紅血球獨特的穩定性、儲存和處理要求，這些要求直接影響血袋設計和配件選擇。基於產品類型，製造商應調整其產品組合策略，涵蓋添加劑溶液袋、成分袋、輻照袋、白血球去除袋和全血袋。同時，他們必須認知到，成分袋包括專用的冷沉澱袋、血漿袋、血小板袋和紅血球袋，每種袋都需要專門的密封和滅菌技術。

區域趨勢導致美洲、歐洲、中東和非洲以及亞太地區在合規性、採購和產品適應性方面有不同的優先事項。

區域市場動態凸顯了不同的營運重點和法規環境，這些因素會影響產品設計、分銷和夥伴關係模式。在美洲，對擴充性、遵守國家血液服務通訊協定以及與大型醫院網路達成整合協議的重視，共同推動了對多功能血袋規格和強大可追溯性的需求。在歐洲、中東和非洲地區，監管碎片化和採購成熟度的差異，為模組化產品、本地化最佳化材料以及靈活的供應結構創造了機遇，從而能夠同時滿足集中式血液服務和分散式醫院採購的需求。

競爭差異化日益依賴材料創新、整合過濾解決方案、在地化生產和基於可追溯性的服務產品。

血袋領域的競爭優勢取決於產品創新、材料採購、監管生命週期管理和通路夥伴關係等多方面的能力。主要企業正透過整合白血球去除解決方案、檢驗的非PVC配方以及可實現可重複無菌填充和密封的生產流程控制，投資於產品差異化。同時，建立本地灌裝和包裝設施以及發展分銷合作夥伴關係等戰略舉措，能夠擴大覆蓋範圍並增強韌性，從而更快地響應血庫和醫院系統的需求，同時降低跨境中斷帶來的風險。

為確保供應彈性、檢驗材料過渡並通過區域生產能力和可追溯性，為製造商提供切實可行的優先行動，以加快臨床應用。

產業領導者應優先考慮一系列切實可行的舉措，以確保供應的持續性、加速創新並提升產品生命週期內的臨床相容性。首先，推進材料過渡路線圖的製定，逐步驗證EVA和PE等非PVC替代品的性能，檢驗指標包括塑化劑遷移、氧氣滲透性和藍圖兼容性等，從而在保持臨床性能的同時，降低長期環境和監管風險。其次，透過雙重採購策略、與關鍵樹脂和過濾介質供應商簽訂長期合約以及製定快速認證備用供應商的緊急時應對計畫，加強供應商風險管理。

結合關鍵相關人員訪談、技術文獻綜述和供應商能力分析的綜合混合方法研究途徑，確保了研究結果具有可操作性。

本研究採用混合方法，整合了訪談、技術文獻綜述、法規指南分析和供應商環境分析，以得出可操作的見解。主要資訊收集自設備工程師、品質保證負責人、採購主管、臨床輸血專家和經銷合作夥伴，旨在了解他們對產品性能、驗證限制和採購期望的跨職能觀點。此外，我們也對最新的同行評審研究、標準文件和與輸液袋材料、白血球去除技術和滅菌方法相關的法規通知進行了嚴格的審查，以補充這些定性研究。

材料、過濾技術和供應鏈韌性的策略整合將決定市場領導，並提高臨床環境中的輸血安全性。

總而言之，醫用血袋產業正處於材料創新、過濾技術進步以及受監管審查和政策轉變驅動的供應鏈重組的交匯點。積極檢驗非PVC材料、投資於整合式白血球去除解決方案並推行本地化生產或填充包裝策略的相關人員，將能夠更好地應對成本壓力、日益複雜的監管以及不斷變化的臨床需求。下一代血袋的成功商業化將取決於嚴格的兼容性測試、有針對性的臨床合作以及能夠滿足血庫、醫院和研究機構多樣化需求的靈活分銷模式。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依血液成分分類的醫用血袋市場

  • 凍結沉澱物
  • 電漿
  • 血小板
  • 紅血球

第9章 依產品類型分類的醫用血袋市場

  • 添加劑袋
  • 原料袋
    • 冷沉澱袋
    • 血漿袋
    • 血小板袋
    • 紅血球袋
  • 輻射袋
  • 白血球去除袋
  • 全血袋

第10章 按材料分類的醫用血袋市場

  • 不含聚氯乙烯
    • 伊娃
    • PE
  • PVC

第11章 依科技分類的醫用血袋市場

  • 內建白血球去除過濾器的袋子
  • 標準包

第12章 按應用分類的醫用血袋市場

  • 收藏
  • 過程
  • 貯存
  • 輸血

第13章 依終端使用者分類的醫用血袋市場

  • 血庫
  • 醫院
  • 研究所

第14章 醫用血袋市場（依通路分類）

  • 離線
  • 線上

第15章 各地區醫用血袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 醫用血袋市場（依集團分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國醫用血袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國醫用血袋市場

第19章：中國醫用血袋市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advacare Pharma
  • B. Braun Melsungen AG
  • Changsha Sinch Medical Instruments Co., Ltd.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Labcaire Systems Ltd.
  • Macopharma SA
  • MEK-ICS Co., Ltd.
  • Ningbo Cland Medical Instruments Co., Ltd.
  • Poly Medicure Limited
  • Shanghai Kehua Bio-Engineering Co., Ltd.
  • Sichuan Nigale Biomedical Co., Ltd.
  • Span Healthcare Private Limited
  • Suru International Pvt. Ltd.
  • Suzhou Jinlu Medical Appliance Co., Ltd.
  • Suzhou Laishi Transfusion Equipment Co., Ltd.
  • Terumo BCT, Inc.
  • Wego Group
Product Code: MRR-867BED9A9E9A

The Medical Blood Bag Market was valued at USD 2.26 billion in 2025 and is projected to grow to USD 2.39 billion in 2026, with a CAGR of 5.45%, reaching USD 3.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.26 billion
Estimated Year [2026] USD 2.39 billion
Forecast Year [2032] USD 3.28 billion
CAGR (%) 5.45%

A concise orientation to prevailing technical, regulatory, and operational variables shaping blood bag development and clinical adoption across stakeholders

The following executive summary synthesizes contemporary dynamics shaping the medical blood bag domain and frames essential considerations for stakeholders across manufacturing, procurement, clinical transfusion services, and research institutions. It offers a concise orientation to the technical, regulatory, and operational variables that are redefining product demand, material selection, and distribution pathways. This introduction situates the reader to understand how advances in filtration, material science, and supply-chain orchestration are converging with evolving clinical best practices to produce meaningful shifts in product design and deployment.

Throughout the analysis, emphasis is placed on cross-functional impacts-from product engineering and validation cycles through to end-user adoption and logistics. Transitional realities such as heightened focus on leukoreduction efficacy and non-PVC materials are explored alongside pragmatic constraints like sterilization compatibility and cold chain demands. The goal of this section is to provide an accessible yet authoritative baseline that enables rapid comprehension of the critical vectors influencing product development priorities, regulatory preparedness, and go-to-market considerations for stakeholders aiming to optimize clinical outcomes while managing cost and supply risk.

Emerging material innovations, filtration advances, and supply chain digitization are jointly redefining competitive advantage in the blood bag ecosystem

The landscape for blood bags is undergoing transformative shifts driven by a confluence of technological refinement, material innovation, and heightened clinical expectations. Advances in integrated leukoreduction filters and improvements in additive solution compatibility are prompting manufacturers to re-evaluate bag architecture and assembly workflows. Concurrently, the rising preference for non-PVC materials such as EVA and PE is catalyzing retooling investments and supplier diversification, as organizations weigh long-term biocompatibility and environmental profiles against established PVC performance attributes.

Regulatory emphasis on transfusion safety and traceability has accelerated digital integration across the supply chain, motivating manufacturers to incorporate labeling, RFID, and data capture features into product lifecycles. These developments are reshaping competitive differentiation, with firms that successfully marry material science, filtration technology, and traceability gaining preferential positioning among progressive hospital systems and sophisticated blood banks. Furthermore, shifting procurement paradigms and channel dynamics are encouraging strategic partnerships between producers and distributors to secure resilient supply while enabling tailored clinical solutions for collection, processing, storage, and transfusion workflows.

Policy-driven tariff dynamics are driving manufacturers toward regional resilience, dual sourcing, and operational efficiencies to protect margins and supply

Tariff adjustments and trade policy changes affecting medical device inputs have introduced a layer of strategic complexity for manufacturers and procurement specialists operating in the United States. In response, firms are conducting targeted sourcing reviews to determine how duties on polymer resins, specialized filters, and assembly components influence landed costs and supplier selection criteria. This period of elevated tariff scrutiny has led many organizations to re-evaluate regional manufacturing footprints, to consider near-shore production options, and to intensify supplier relationship management as a means to mitigate exposure to cross-border cost variability.

As companies assess the implications of tariff shifts, they are increasingly prioritizing contractual flexibility and dual-sourcing strategies to preserve continuity of supply. At the same time, those with vertically integrated capabilities or established domestic production lines are leveraging these assets to secure preferred positioning with major hospital systems and blood service providers. The tariff environment has also sharpened internal focus on process efficiencies and waste reduction during component assembly and filling operations, as organizations seek to preserve margin and maintain competitive pricing without compromising regulatory compliance or clinical performance.

Segment-focused insights reveal how component, product type, material, end-user, channel, application, and technology variables drive differentiated product and commercialization strategies

Deep segmentation analysis illuminates differentiated demand drivers and product requirements across component, product type, material, end user, channel, application, and technology dimensions. Based on blood component, product development and inventory planning must accommodate the distinct stability, storage, and handling requirements of cryoprecipitate, plasma, platelets, and red blood cells, which directly inform bag formulation and accessory inclusion. Based on product type, manufacturers need to align portfolio strategies to cover additive solution bags, component bags, irradiation bags, leukocyte reduction bags, and whole blood bags, while recognizing that component bags include specialized cryoprecipitate bags, plasma bags, platelet bags, and red cell bags that each demand tailored sealing and sterile processing techniques.

Based on material, the trade-offs between PVC and non-PVC options such as EVA and PE extend beyond environmental considerations to affect oxygen permeability, plasticizer migration, and interchangeability with standardized tubing and connectors. Based on end user, the distinct procurement behaviors and clinical workflows of blood banks, hospitals, and research institutes require differentiated service, packaging, and quality documentation. Based on channel, distribution strategies must be optimized for direct sales, traditional distributors, and online fulfillment mechanisms that influence lead times and lot traceability. Based on application, the product set must service collection, processing, storage, and transfusion phases, each with specific closure integrity, bag geometry, and temperature control demands. Based on technology, portfolios should reflect the growing importance of integrated leukoreduction filter bags alongside standard bag configurations to meet clinical expectations for leukocyte removal and transfusion safety.

Regional dynamics create distinct priorities in compliance, procurement, and product adaptation across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional market dynamics underscore divergent operational priorities and regulatory environments that affect product design, distribution, and partnership models. In the Americas, emphasis is placed on scalability, compliance with national blood service protocols, and consolidation agreements with major hospital networks, which together influence demand for versatile bag formats and robust traceability features. In Europe, Middle East & Africa, regulatory fragmentation and varying procurement maturities create opportunities for modular product offerings, regionally optimized materials, and flexible supply arrangements that accommodate both centralized blood services and decentralized hospital procurement.

In Asia-Pacific, rapid healthcare expansion and investments in transfusion infrastructure are advancing adoption of advanced filtration technologies and non-PVC materials, while also placing a premium on cost-effective manufacturing and localized support models. Across all regions, manufacturers must calibrate market entry strategies to regulatory expectations for biocompatibility and sterility assurance, while tailoring commercial approaches to the distinctive procurement cycles and clinical pathways that characterize blood banks, hospitals, and research institutes in each geography.

Competitive differentiation is increasingly driven by material innovation, integrated filtration solutions, localized manufacturing, and traceability-enabled service offerings

Competitive positioning in the blood bag sector hinges on capabilities spanning product innovation, material sourcing, regulatory lifecycle management, and channel partnerships. Leading firms are investing in product differentiation through integrated leukoreduction solutions, validated non-PVC formulations, and manufacturing process controls that enable reproducible sterile filling and sealing outcomes. At the same time, strategic moves such as establishing localized fill-and-finish facilities or forging distribution alliances amplify reach and resilience, enabling faster response times to blood banks and hospital systems while reducing exposure to cross-border disruptions.

Collaboration between R&D, quality, and commercial teams is proving critical to accelerate product adoption, particularly where changes in material necessitate extensive compatibility testing with additive solutions, storage protocols, and medical devices. Companies that can effectively document clinical equivalence, secure timely regulatory clearances, and provide robust technical service are positioned to capture preference among end users. Additionally, organizations that deploy digital tools for lot traceability and post-market surveillance gain differentiation by supporting safety reporting and inventory management needs of large transfusion centers and national blood services.

Practical, prioritized actions for manufacturers to secure supply resilience, validate material transitions, and accelerate clinical adoption through regional capacity and traceability

Industry leaders should prioritize a set of actionable initiatives to safeguard supply continuity, accelerate innovation, and improve clinical alignment across the product lifecycle. First, pursue material transition roadmaps that incrementally validate non-PVC alternatives such as EVA and PE against performance criteria for plasticizer migration, oxygen permeability, and sterilization compatibility to reduce long-term environmental and regulatory risk while maintaining clinical performance. Next, enhance supplier risk management through dual-sourcing strategies, long-term agreements with critical resin and filtration suppliers, and contingency plans for rapid qualification of secondary vendors.

Further, integrate product-level traceability and data capture capabilities to support hemovigilance and inventory management for large blood banks and hospital systems. Invest in modular manufacturing and fill-and-finish capacity in target regions to shorten lead times and mitigate tariff-driven cost exposure. Strengthen cross-functional processes to accelerate compatibility testing when combining additive solutions with alternative bag materials, and establish robust clinical engagement programs that secure early adopters for new bag configurations and filtration technologies. Finally, align commercial models to support diverse channel preferences, providing differentiated support for direct institutional customers, distributor partners, and digital procurement platforms to maximize market access and responsiveness.

An integrated, mixed-methods research approach combining primary stakeholder interviews, technical literature review, and supplier capability mapping to ensure actionable insights

This research synthesis is grounded in a mixed-methods approach that integrates primary interviews, technical literature review, regulatory guidance analysis, and supplier landscape mapping to produce actionable insights. Primary inputs were gathered from device engineers, quality assurance professionals, procurement leaders, clinical transfusion specialists, and distribution partners to capture cross-functional perspectives on product performance, validation constraints, and procurement expectations. These qualitative engagements were supplemented by a rigorous review of contemporary peer-reviewed studies, standards documentation, and regulatory notices relevant to bag materials, leukoreduction technologies, and sterilization methods.

To ensure robustness, methodological triangulation was applied by cross-referencing interview findings with technical specifications, manufacturing process descriptions, and publicly available regulatory frameworks. Material compatibility assessments and technology evaluations were contextualized with documented clinical workflows for collection, processing, storage, and transfusion to reflect real-world operational priorities. The research team also applied comparative supplier profiling and capability mapping to identify strategic differentiation and potential bottlenecks across manufacturing and distribution networks, enabling recommendations that are both evidence-based and operationally actionable.

Strategic convergence of material, filtration, and supply resilience initiatives will determine market leaders and improve transfusion safety across clinical settings

In conclusion, the medical blood bag sector is at the intersection of material innovation, filtration technology advancement, and supply-chain realignment driven by regulatory scrutiny and policy shifts. Stakeholders who proactively validate non-PVC materials, invest in integrated leukoreduction solutions, and pursue regional manufacturing or fill-and-finish strategies will be better positioned to manage cost pressures, regulatory complexity, and evolving clinical expectations. The successful commercialization of next-generation bag formats will depend on rigorous compatibility testing, targeted clinical engagement, and flexible distribution models that meet the diverse needs of blood banks, hospitals, and research institutes.

Decision-makers should treat current market dynamics as an impetus for disciplined portfolio prioritization and cross-functional coordination, ensuring that R&D, quality, procurement, and commercial teams act in concert to reduce time to clinical adoption while preserving patient safety. By following an evidence-based path that balances innovation with operational resilience, organizations can secure competitive advantage and contribute to improved transfusion outcomes across geographies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Blood Bag Market, by Blood Component

  • 8.1. Cryoprecipitate
  • 8.2. Plasma
  • 8.3. Platelets
  • 8.4. Red Blood Cells

9. Medical Blood Bag Market, by Product Type

  • 9.1. Additive Solution Bags
  • 9.2. Component Bags
    • 9.2.1. Cryoprecipitate Bags
    • 9.2.2. Plasma Bags
    • 9.2.3. Platelet Bags
    • 9.2.4. Red Cell Bags
  • 9.3. Irradiation Bags
  • 9.4. Leukocyte Reduction Bags
  • 9.5. Whole Blood Bags

10. Medical Blood Bag Market, by Material

  • 10.1. Non Pvc
    • 10.1.1. Eva
    • 10.1.2. Pe
  • 10.2. Pvc

11. Medical Blood Bag Market, by Technology

  • 11.1. Integrated Leukoreduction Filter Bags
  • 11.2. Standard Bags

12. Medical Blood Bag Market, by Application

  • 12.1. Collection
  • 12.2. Processing
  • 12.3. Storage
  • 12.4. Transfusion

13. Medical Blood Bag Market, by End User

  • 13.1. Blood Banks
  • 13.2. Hospitals
  • 13.3. Research Institutes

14. Medical Blood Bag Market, by Channel

  • 14.1. Offline
  • 14.2. Online

15. Medical Blood Bag Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Blood Bag Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Blood Bag Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Medical Blood Bag Market

19. China Medical Blood Bag Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Advacare Pharma
  • 20.6. B. Braun Melsungen AG
  • 20.7. Changsha Sinch Medical Instruments Co., Ltd.
  • 20.8. Fresenius Kabi AG
  • 20.9. Fresenius SE & Co. KGaA
  • 20.10. Grifols, S.A.
  • 20.11. Haemonetics Corporation
  • 20.12. JMS Co., Ltd.
  • 20.13. Kawasumi Laboratories, Inc.
  • 20.14. Labcaire Systems Ltd.
  • 20.15. Macopharma SA
  • 20.16. MEK-ICS Co., Ltd.
  • 20.17. Ningbo Cland Medical Instruments Co., Ltd.
  • 20.18. Poly Medicure Limited
  • 20.19. Shanghai Kehua Bio-Engineering Co., Ltd.
  • 20.20. Sichuan Nigale Biomedical Co., Ltd.
  • 20.21. Span Healthcare Private Limited
  • 20.22. Suru International Pvt. Ltd.
  • 20.23. Suzhou Jinlu Medical Appliance Co., Ltd.
  • 20.24. Suzhou Laishi Transfusion Equipment Co., Ltd.
  • 20.25. Terumo BCT, Inc.
  • 20.26. Wego Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL BLOOD BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL BLOOD BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ADDITIVE SOLUTION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ADDITIVE SOLUTION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ADDITIVE SOLUTION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLASMA BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PLATELET BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RED CELL BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY IRRADIATION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY IRRADIATION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY IRRADIATION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY LEUKOCYTE REDUCTION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY LEUKOCYTE REDUCTION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY LEUKOCYTE REDUCTION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY WHOLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY EVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY EVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY EVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY INTEGRATED LEUKOREDUCTION FILTER BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY INTEGRATED LEUKOREDUCTION FILTER BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY INTEGRATED LEUKOREDUCTION FILTER BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STANDARD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STANDARD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STANDARD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MEDICAL BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY COMPONENT BAGS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY NON PVC, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEDICAL BLOOD BAG MARKET SIZE, BY CHANNEL, 2018-2032 (USD MILLION)